In the HCT116 (colon adenocarcinoma) s.c. xenograft model, treatment with GH-pAb1 was initiated when tumor size reached 50 mm3, and it was maintained twice a week for 28 days (Figure 10A). The gene discussed is PABPC1; the disease is neoplasm.